Development of SARS-CoV-2 variant protein microarray for profiling humoral immunity in vaccinated subjects

SARS-CoV-2 is quickly evolving from wild-type to many variants and spreading around the globe. Since many people have been vaccinated with various types of vaccines, it is crucial to develop a high throughput platform for measuring the antibody responses and surrogate neutralizing activities against...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Tzong-Shiann, Du, Pin-Xian, Su, Wen-Yu, Santos, Harvey M., Lin, Ya-Lan, Chou, Yi-Yu, Keskin, Batuhan Birol, Pau, Chi Ho, Syu, Guan-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821029/
https://www.ncbi.nlm.nih.gov/pubmed/35168024
http://dx.doi.org/10.1016/j.bios.2022.114067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821029/
https://www.ncbi.nlm.nih.gov/pubmed/35168024
http://dx.doi.org/10.1016/j.bios.2022.114067

Ejemplares similares